Cultured Rat Microglia Express C1q and Receptor for C1q: Implications for Amyloid Effects on Microglia
Overview
Affiliations
Senile plaques, the pathological hallmark of Alzheimer's disease (AD), are associated with complement components, including C1q. Reactive microglia appear to be involved in the later stages of plaque development. Since tissue macrophages are known to synthesize C1q, cultured rat microglia were examined for C1q immunoreactivity. Anti-C1q staining was detected, particularly in process-bearing microglia, indicating constitutive expression of C1q. Thus, microglia could provide a source of C1q for plaques even before becoming reactive. Since it has been previously shown that C1q binds beta 1-42, the major constituent of senile plaques, and since beta 1-42 is toxic to microglia in vitro, we asked if preincubation of beta 1-42 with C1q alters either metabolic indices of amyloid-induced degeneration in microglial cultures or the formation of amyloid deposits on these cells. While electron microscopic analysis of negatively stained amyloid fibrils confirmed that pre-incubation with C1q induced the association of C1q with the fibrils, no effect of the binding of C1q to beta 1-42 on beta 1-42 toxicity in microglia was observed. Interestingly, immunoreactivity for the C1q receptor that is known to modulate phagocytosis was found and was up-regulated in non-process-bearing microglia by interferon-gamma. While these data exclude a role for the C1q receptor in beta 1-42 toxicity in microglia, the observed expression and up-regulation of C1q receptor on microglia by interferon-gamma would be consistent with a role for C1q in complement-mediated inflammatory responses in AD and as a potential activator of microglial function in plaques.
Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q.
Niewold P, Dijkstra D, Cai Y, Goletti D, Palmieri F, van Meijgaarden K Sci Rep. 2023; 13(1):11617.
PMID: 37464009 PMC: 10354225. DOI: 10.1038/s41598-023-38889-x.
Wu J, Bie B, Foss J, Naguib M Mol Neurobiol. 2020; 57(5):2290-2300.
PMID: 32008166 DOI: 10.1007/s12035-020-01885-7.
Lim J, Grinstein S, Roth Z Front Cell Infect Microbiol. 2017; 7:191.
PMID: 28589095 PMC: 5440456. DOI: 10.3389/fcimb.2017.00191.
Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibition.
Rojanathammanee L, Floden A, Manocha G, Combs C J Neuroinflammation. 2015; 12:42.
PMID: 25889879 PMC: 4355356. DOI: 10.1186/s12974-015-0255-2.
Increased complement C1q level marks active disease in human tuberculosis.
Cai Y, Yang Q, Tang Y, Zhang M, Liu H, Zhang G PLoS One. 2014; 9(3):e92340.
PMID: 24647646 PMC: 3960215. DOI: 10.1371/journal.pone.0092340.